Dr Ralph & Marian Falk Medical Research TR
Historical funder research: IRS Form 990-PF filings from US private foundations, showing who funded what in past years. This is not a list of currently open grant calls, and we do not track open RFPs from private foundations. From public IRS Form 990-PF filings (latest on file for this funder: tax year 2024). Coverage: tax years 2019–2025. Freshness: the IRS releases these returns 1.5–2+ years after the tax year ends, so 2025 is still partial and a funder's newest grants may not appear yet. Last updated: November 14, 2026. Filings can contain errors, so confirm current priorities and deadlines with the funder before applying.
Year 2025 is still partial because many returns have not been filed or released yet. That is a freshness issue — coverage in our dataset is tax years 2019–2025.
Only 58.2% of this funder's organizational grants could be linked to an IRS cause code.
- Form & materials
- Go to hria.org/tmf/falktap/ for applications and procedures
- Deadlines
- AUGUST
- Restrictions
- MEDICAL RESEARCH TO IMPROVE TREATMENTS OF THE PAST AND EVENTUALLY FIND CURES FOR DISEASES FOR WHICH NO DEFINITE CURE IS KNOWN. MIDWEST RESEARCH LOCATION PREFERENCE.
| Recipient | Location | Purpose (as filed) | Amount | Tax yr |
|---|---|---|---|---|
| Case Western Reserve University | Cleveland, OH | IMMUNOTHERAPY FOR B CELL | $355,809 | 2024 |
| Yale University - School of Medicine | New Haven, CT | MAKING CANCER CELLS LOOK | $348,252 | 2024 |
| Indiana University | Bloomington, IN | PIM2 MODULATOR-MULTIPLE | $340,879 | 2024 |
| Medical College of Wisconsin | Milwaukee, WI | PAIN THERAPY - SENSORY | $334,583 | 2024 |
| Thomas Jefferson University | Philadelphia, PA | PROTACS FOR TARGETING BRCA | $333,333 | 2024 |
| Cleveland Clinic Foundation | Cleveland, OH | DEVELOPMENT OF NEW DRUG FOR | $331,873 | 2024 |
| Board Regents of University of Wisconsin | Milwaukee, WI | IMPROVE DIAGNOSIS OF BREAST | $330,487 | 2024 |
| Medical College of Wisconsin | Milwaukee, WI | NEW DRUGS TO TREAT | $315,981 | 2024 |
| Universityof Minnesota | Minneapolis, MN | T3 THERAPY - HEART FAILURE | $308,897 | 2024 |
| University of Minnesota | Minneapolis, MN | OPTIMIZED MECHANISM BASED | $284,681 | 2024 |
| University of Chicago | Chicago, IL | METASTIC LUNG CANCER PHASE | $268,735 | 2024 |
| Purdue University | West Lafayette, IN | ADVANCING MICRO RNAS AS | $257,044 | 2024 |
| Northwestern University | Evanston, IL | THERAPY FOR CHRONIC KIDNEY | $210,398 | 2024 |
| University of Iowa | Iowa City, IA | VASCULAR HEALTH TARGETING | $208,319 | 2024 |
| University of Minnesota | Minneapolis, MN | SYSTEMIC BACTEREMIA - HOST | $203,837 | 2024 |
| Cleveland Clinic Foundation | Cleveland, OH | TREATMENT OF COMPLEX | $186,955 | 2024 |
| Ohio State University | Columbus, OH | MELANOMA ONSET & RECURRENCE | $178,604 | 2024 |
| University of Minnesota | Minneapolis, MN | DEVELOP IL-15 - MALARIA | $176,327 | 2024 |
| Shirley Ryan Ability Lab | Chicago, IL | RESTORE DIAPHRAGM - NERVE | $175,864 | 2024 |
| Mayo Clinic | Rochester, MN | CD-19 TARGETED CAR-MSC19 IN | $175,575 | 2024 |
| Regents of University of Michigan | Ann Arbor, MI | NEURO-CARDIAC MECHANISMS OF | $175,000 | 2024 |
| Michigan State University | East Lansing, MI | DEVELOP NEW ODC INHIBITORS | $175,000 | 2024 |
| Loyola University of Chicago | Chicago, IL | INHIBITORS FOR TRIPLE | $175,000 | 2024 |
| University of Cincinnati | Cleveland, OH | DEVELOP IMPROVED METHOD OF | $175,000 | 2024 |
| Washington University | St Louis, MO | STEM CELL DERIVED ISLETS | $175,000 | 2024 |
Grants to individuals are counted but not named.
The free funder search finds foundations that funded organizations like your client's, by cause and location. Free templates: multi-client grant calendar, grant tracker. GrantCorral is a workspace for grant consultants with several clients; founding members get 60 days free on Consultant, no card required, then 50% off the first year if they stay.